Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver.
Ontology highlight
ABSTRACT: Glucocorticoids are important regulators of metabolism and immune function. Synthetic glucocorticoids are extensively used for immunosuppression/anti-inflammatory therapy. Since the glucocorticoid receptor (GR) is central to most hormone effects; its in vivo regulation will influence hormone/drug action. An alternative splice variant, GR?, is present in humans and may function as a dominant negative regulator of GR transcriptional activity. Recently, a similar splice variant was reported in mouse, although the mechanism of alternative splicing differs from that in humans. We present evidence that a splice variant of GR with an alternative C-terminus also occurs in the rat by a mechanism of intron inclusion. A highly quantitative qRT-PCR assay for the simultaneous measurement of both splice variants in a single sample was developed in order to accurately measure their regulation. We used this assay to assess the tissue specific expression of both mRNAs, and demonstrate that GR? is predominant in all tissues. In addition, the regulation of both GR? and GR? mRNA by various physiological factors in rat liver was assessed. GR? showed a robust circadian rhythm, which was entrained with the circadian oscillation of the endogenous hormone. Time series experiments showed that both corticosteroids and LPS but not insulin dosing resulted in the transient down-regulation of GR? mRNA. LPS treatment also resulted in down-regulation of GR? expression. A modest up-regulation in GR? expression was observed only in animals having chronically elevated plasma insulin concentrations. However the expression of GR? was significantly lower than that of GR? in all cases.
SUBMITTER: DuBois DC
PROVIDER: S-EPMC3552070 | biostudies-literature | 2013 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA